Sangram Singh

Sangram Singh

Active Director Director DIN 01262169
DIN 01262169 First appointment Feb 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 4 historical roles
Total affiliations 9 Since Feb 2007
Shareholding value •••• Premium profile

About Sangram Singh

Data last updated:

Sangram Singh is a Director at Ultra Drugs Private Limited (since 2015), Nominee Director at Ultra Drugs Formulations Private Limited (since 2020) and Director at Viva Drugs Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Pharma, Information Technology and Life Sciences. The 3 current companies with reported revenue have a combined latest revenue of ₹343 Cr; the largest is Ultra Drugs Private Limited at ₹308 Cr (FY 2024). Earlier, Sangram Singh was a Director at Avenue Strategic Consultants Private Limited (2012–2018) and Director at Dakhson Formulations Private Limited (from 2007) and 2 more.

DIN 01262169
Primary Designation Director
Industry Pharma
First Appointment 08 Feb 2007
Oldest Company Age 30 yrs
Largest company Ultra Drugs Private Limited · ₹308 Cr (FY 2024)
Combined revenue ₹343 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ultra Drugs Private Limited U24230CH2005PTC029023
Director30 Jun 20152005₹308 Cr (FY 2024)Active
Nominee Director04 Feb 20202020₹24.17 Cr (FY 2024)Active
Viva Drugs Private Limited U24231PB1996PTC017590
Director30 Sep 20251996₹10.80 Cr (FY 2025)Active
Ultra Bytes Private Limited U72900CH2015PTC035547
Director25 May 20152015Active
Director08 May 20082008Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Feb 20122009₹4.73 Cr (FY 2018)Active
Dakhson Formulations Private Limited U24232HP2007PTC030617
Director08 Feb 20072007Strike Off
Minson Biosis Private Limited U24232HP2007PTC030744
Director25 May 20072007Strike Off
Designated Partner20 Feb 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ultra Drugs Private Limited
Dakhson Formulations Private Limited
Minson Biosis Private Limited
Ultra Bytes Private Limited
Premium access

Shareholding and investment profile for Sangram Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangram Singh

Sangram Singh currently holds 5 directorships: Ultra Drugs Private Limited (Director, since 30 Jun 2015, revenue ₹308 Cr (FY 2024)); Ultra Drugs Formulations Private Limited (Nominee Director, since 04 Feb 2020, revenue ₹24.17 Cr (FY 2024)); Viva Drugs Private Limited (Director, since 30 Sep 2025, revenue ₹10.80 Cr (FY 2025)); Ultra Bytes Private Limited (Director, since 25 May 2015); Dakhson Research & Development Foundation (Director, since 08 May 2008).

Sangram Singh was first appointed on 08 Feb 2007 as Director at Dakhson Formulations Private Limited. The most recent appointment on record is 30 Sep 2025 at Viva Drugs Private Limited.

The 3 current companies of Sangram Singh that report revenue have a combined latest revenue of ₹343 Cr: Ultra Drugs Private Limited ₹308 Cr (FY 2024); Ultra Drugs Formulations Private Limited ₹24.17 Cr (FY 2024); Viva Drugs Private Limited ₹10.80 Cr (FY 2025).

Sangram Singh held 4 earlier board appointments: Avenue Strategic Consultants Private Limited (Director, 21 Feb 2012 to 30 Apr 2018); Dakhson Formulations Private Limited (Director, from 08 Feb 2007); Minson Biosis Private Limited (Director, from 25 May 2007); Able Venture Partners Llp (Designated Partner, from 20 Feb 2013).

The current boards of Sangram Singh's companies include Minna Jakhar (Ultra Drugs Private Limited), Sandeep Kumar Arora (Ultra Drugs Private Limited), Sonali Dalla (Viva Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available